Antimutagenic activity of berry extracts

S Hope Smith1, Patricia L Tate, George Huang

  • 1Department of Microbiology, Clemson University, Clemson, SC 29634, USA.

Journal of Medicinal Food
|January 27, 2005
PubMed

Insights

Berries like strawberries, blueberries, and raspberries show significant antimutagenic properties. Specific berry compounds, particularly tannins from strawberries, effectively inhibit cancer-causing mutations.

Area of Science:

  • Phytochemistry
  • Cancer Research
  • Genetics

Background:

  • Plants are recognized sources of anti-tumor and chemopreventative compounds.
  • Identifying dietary phytochemicals for cancer prevention and intervention is crucial.
  • Cancer initiation involves genomic damage to somatic cells, leading to mutations.

Purpose of the Study:

  • To evaluate the antimutagenic potential of berry fruits (strawberry, blueberry, raspberry).
  • To assess the efficacy of berry juices and extracts against specific mutagens.
  • To identify specific berry components responsible for inhibiting mutagenesis.

Main Methods:

  • Fresh juices and organic solvent extracts from strawberries, blueberries, and raspberries were prepared.
  • Antimutagenic activity was tested against methyl methanesulfonate (direct-acting mutagen) and benzo[a]pyrene (metabolically activated carcinogen).
  • Ethanol extracts from specific strawberry and blueberry cultivars were further analyzed.

Main Results:

  • Juices from all tested berries significantly inhibited mutagenesis induced by both methyl methanesulfonate and benzo[a]pyrene.
  • Ethanol extracts from freeze-dried strawberry and blueberry fruits also demonstrated antimutagenic effects.
  • A hydrolyzable tannin-rich fraction from 'Sweet Charlie' strawberry cultivar exhibited the highest efficacy in mutation inhibition.

Conclusions:

  • Strawberry, blueberry, and raspberry fruits possess significant antimutagenic properties.
  • Berry phytochemicals, especially tannins from strawberries, can inhibit chemically induced mutations.
  • These findings support the role of berries in dietary cancer prevention strategies.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...